The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer.
| Image |  |
|---|---|
| Description | scientific article published on 29 January 2009 |
| Author/s |
author: Rikke Fredslund Andersen |
| Publication date | January 29, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |